An essential component of allogeneic and autologous hematopoietic cell transplantation
(HCT) is the conditioning regimen administered before the hematopoietic cell infusion. Early …

Major advances have been made in the field of immunology in the past two decades. A
better understanding of the molecular and cellular mechanisms controlling the immune …

Targeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field
of research spanning nearly 50 years, evolving with advancing technologies in molecular …

Unlike cytotoxic agents that indiscriminately affect rapidly dividing cells, newer
antineoplastic agents such as targeted therapies and immunotherapies are associated with …

Enormous progress has been made in the treatment of diffuse large B-cell lymphoma
(DLBCL), mostly due to the anti-CD20 antibody rituximab. More than 50% of elderly DLBCL …

The use of radiopharmaceutical therapies (RPTs) in the treatment of cancers is growing
rapidly, with more agents becoming available for clinical use in last few years and many new …

Background: Several of the currently used anticancer drugs may variably affect thyroid
function, with impairment ranging from modified total but not free concentration of thyroid …

Background There is currently limited experience on the feasibility and efficacy of
autologous stem cell transplantation in elderly patients with diffuse large B-cell lymphoma …

We compared outcomes of 916 diffuse large B cell lymphoma (DLBCL) patients age≥ 18
years undergoing first autologous (n= 837) or myeloablative allogeneic hematopoietic cell …

BACKGROUND. The objective of this study was to test cladribine (2‐CDA) alone and in
combination with rituximab in patients with mantle cell lymphoma (MCL). METHODS …